top of page
Vocal.
Search
Innovative Financing for Cell and Gene Therapies
The emergence of gene therapy and other transformative therapies has magnified concerns about affordability among payers, providers and...
Ulrich Neumann, MBA MSc MA
Apr 2, 20201 min read
Key Trends in US Specialty Pharmacy. Payer Perspectives and Developer Strategies, 2020-23
Payer perspectives and developer strategies for specialty drug coverage and utilization. Report, 33 pp.
Ulrich Neumann, MBA MSc MA
Apr 2, 20201 min read
AMCP Poster: A Systematic Comparison of Status Quo and Future Expectations for Novel Drug Financing
Journal of Managed Care and Specialty Pharmacy; April 2020 · Apr 1, 2020
Ulrich Neumann, MBA MSc MA
Apr 1, 20201 min read
AMCP Poster: A Survey-Based Analysis of Formulary Decision Making and Utilization Management Trends
Journal of Managed Care and Specialty Pharmacy; April 2020 · Apr 1, 2020
Ulrich Neumann, MBA MSc MA
Apr 1, 20201 min read
The Rise of Cost Effectiveness Considerations in the US.
Neumann U. (2020). The Rise of Cost Effectiveness Considerations in the US. Payer Views and Innovator Strategies. Certara.
Ulrich Neumann, MBA MSc MA
Feb 21, 20201 min read
Directly blog
bottom of page